India’s drug regulator has refused to disclose key information about a controversial government study that provided Indian girls a vaccine designed to protect them from Cervical Cancer, amplifying suspicions about the study’s objectives. The Drug Controller General of India (DCGI) has refused to release for public scrutiny the study’s protocols, which are expected to contain information about its purpose and methodology, a set of health activists said yesterday. The Union government had...

The three-member committee, set up to look into alleged irregularities in the conduct of studies on use of Human Papilloma Virus (HPV) vaccine by PATH in India, has submitted its final report to the Ministry of Health and Family Welfare. This information was given to the Parliamentary Standing Committee on Health and Family Welfare by Director-General of Indian Council of Medical Research (ICMR) V. M. Katoch at a meeting here on...

Rules out blanket ban on or approval of such studies ‘HPV vaccination should supplement Cervical Cancer screening programme' The three-member committee, set up to probe the alleged irregularities in conducting studies using human papillomavirus (HPV) vaccine by PATH in India, has identified several deficiencies in the planning and implementation of the project leading “to a crisis requiring suspension of the study,” but has fallen short of fixing responsibility on any individual or...

Only 12% of India's 355 million menstruating women use sanitary napkins (SNs). Over 88% of women resort to shocking alternatives like unsanitised cloth, ashes and husk sand. Incidents of Reproductive Tract Infection (RTI) is 70% more common among these women. Inadequate menstrual protection makes adolescent girls (age group 12-18 years) miss 5 days of school in a month (50 days a year). Around 23% of these girls actually drop out of school after...

Adjuvants with severe physiological side effect have been administered to hundreds of children during vaccine trials conducted at a government hospital in Indore over the last few years, and that too without the approved Standard Operating Procedure (SOP). The trials conducted on at least 836 children at the Chacha Nehru Bal Chikitsalaya, the paediatric division of the Maharaja Yashwantrao Hospital, were spiked with adjuvants that contain high levels of mercury, aluminium,...